{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:25:38Z","timestamp":1761675938246,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.thromres.2012.02.035","type":"journal-article","created":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T14:46:07Z","timestamp":1331217967000},"page":"S57-S61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S2","title":["A review of current methods for assessing hemostasis in vivo and introduction to a potential alternative approach"],"prefix":"10.1016","volume":"129","author":[{"given":"Mallory R.","family":"Scola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie M.","family":"Baggesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim C.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel S.","family":"Key","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina M.","family":"Gallippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2012.02.035_bb0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01714977","article-title":"Hemophilia treatment in historical perspective: a review of medical and social developments","volume":"62","author":"Rosendaal","year":"1991","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.thromres.2012.02.035_bb0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2516.2005.01170.x","article-title":"Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience","volume":"12","author":"Carcao","year":"2006","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.thromres.2012.02.035_bb0215","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00431-004-1542-6","article-title":"Haemophilia A in two premature infants","volume":"164","author":"Bidlingmaier","year":"2005","journal-title":"Eur J Pediatr"},{"issue":"Suppl. 4","key":"10.1016\/j.thromres.2012.02.035_bb0220","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2516.2004.01005.x","article-title":"Molecular basis of haemophilia A","volume":"10","author":"Oldenburg","year":"2004","journal-title":"Haemophilia"},{"issue":"Suppl. 4","key":"10.1016\/j.thromres.2012.02.035_bb0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2516.2004.00996.x","article-title":"New high-technology products for the treatment of haemophilia","volume":"10","author":"Pipe","year":"2004","journal-title":"Haemophilia"},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2012.02.035_bb0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2516.2004.00938.x","article-title":"Surgery in haemophilic patients with inhibitor: 20 years of experience","volume":"10","author":"Quintana-Molina","year":"2004","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.thromres.2012.02.035_bb0235","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2516.2004.00932.x","article-title":"Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma\/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A","volume":"10","author":"Tarantino","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2012.02.035_bb0040","unstructured":"A. O'Conner. Four Drugs Cause Most Hospitalizations in Older Adults. New York Times. November 23 2011."},{"issue":"2","key":"10.1016\/j.thromres.2012.02.035_bb0240","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ilar.50.2.144","article-title":"Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von Willebrand disease, and factor VII deficiency","volume":"50","author":"Nichols","year":"2009","journal-title":"ILAR J"},{"issue":"25","key":"10.1016\/j.thromres.2012.02.035_bb0245","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.thromres.2012.02.035_bb0250","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMe1111138","article-title":"Merry christmas for patients with hemophilia B","volume":"365","author":"Ponder","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.thromres.2012.02.035_bb0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/0022-3859.30322","article-title":"Use of recombinant factor VIIa for emergency reversal of anticoagulation","volume":"53","author":"Ingerslev","year":"2007","journal-title":"J Postgrad Med"},{"issue":"2","key":"10.1016\/j.thromres.2012.02.035_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11739-008-0201-8","article-title":"Emergency reversal of antithrombotic treatment","volume":"4","author":"Levi","year":"2009","journal-title":"Intern Emerg Med"},{"issue":"3","key":"10.1016\/j.thromres.2012.02.035_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tmrv.2008.02.007","article-title":"Evidence for the use of recombinant factor VIIa in the prevention and treatment of bleeding in patients without hemophilia","volume":"22","author":"Birchall","year":"2008","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.thromres.2012.02.035_bb0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/asheducation-2008.1.36","article-title":"What is the evidence for the off-label use of recombinant factor VIIa (rFVIIa) in the acute reversal of warfarin? ASH evidence-based review 2008","author":"Rosovsky","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.thromres.2012.02.035_bb0260","first-page":"637","article-title":"Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure","volume":"41","author":"Langdell","year":"1953","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.thromres.2012.02.035_bb0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00000441-191304000-00004","article-title":"A clinical study of the coagulation time of blood","volume":"145","author":"Lee","year":"1913","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.thromres.2012.02.035_bb0090","unstructured":"T.C. Nichols, H.W.G. Franck, C. Franck, R.A. Raymer, E.P. Merricks. Sensitivity of Whole Blood Clotting Time and Activated Partial Thromboplastin Time for Canine Factor IX. J Thromb Haemost accepted for publication."},{"issue":"3","key":"10.1016\/j.thromres.2012.02.035_bb0265","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood.V60.3.727.727","article-title":"A canine model of hemophilic (factor VIII:C deficiency) bleeding","volume":"60","author":"Giles","year":"1982","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2012.02.035_bb0270","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.V72.1.335.bloodjournal721335","article-title":"In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency)","volume":"72","author":"Giles","year":"1988","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2012.02.035_bb0275","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1182\/blood.V58.5.868.868","article-title":"Hemophilic dog model for evaluating therapeutic effectiveness of plasma protein fractions","volume":"58","author":"Kingdon","year":"1981","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2012.02.035_bb0280","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-2002-32661","article-title":"Preclinical pharmacology of albumin-free B-domain deleted recombinant factor VIII","volume":"28","author":"Brinkhous","year":"2002","journal-title":"Semin Thromb Hemost"},{"issue":"24","key":"10.1016\/j.thromres.2012.02.035_bb0285","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1073\/pnas.82.24.8752","article-title":"Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs","volume":"82","author":"Brinkhous","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.thromres.2012.02.035_bb0290","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood.V88.7.2603.bloodjournal8872603","article-title":"Recombinant human factor IX: replacement therapy, prophylaxis, and pharmacokinetics in canine hemophilia B","volume":"88","author":"Brinkhous","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2012.02.035_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1002658","article-title":"A critical reappraisal of the bleeding time","volume":"16","author":"Rodgers","year":"1990","journal-title":"Semin Thromb Hemost"},{"issue":"9","key":"10.1016\/j.thromres.2012.02.035_bb0300","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2460\/ajvr.1987.48.09.1337","article-title":"Buccal mucosa bleeding times of healthy dogs and of dogs in various pathologic states, including thrombocytopenia, uremia, and von Willebrand's disease","volume":"48","author":"Jergens","year":"1987","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.thromres.2012.02.035_bb0135","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1152\/ajplegacy.1942.136.3.360","article-title":"The anomaly of a normal Duke's and very prolonged saline bleeding time in swine suffering from an inherited bleeding disease","volume":"136","author":"Mertz","year":"1942","journal-title":"Am J Physiol"},{"key":"10.1016\/j.thromres.2012.02.035_bb0305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2010\/461238","article-title":"Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies","volume":"2010","author":"Nichols","year":"2010","journal-title":"Thrombosis"},{"issue":"4","key":"10.1016\/j.thromres.2012.02.035_bb0310","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1073\/pnas.86.4.1382","article-title":"Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease","volume":"86","author":"Brinkhous","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2012.02.035_bb0150","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1073\/pnas.82.24.8752","article-title":"Purified human factor VIII procoagulant protein: Comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs","volume":"82","author":"Brinkhous","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2012.02.035_bb0155","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood.V88.7.2603.bloodjournal8872603","article-title":"Recombinant human factor IX: Replacement therapy, prophylaxis, pharmacokinetics, and immunogenicity in canine hemophilia B","volume":"88","author":"Brinkhous","year":"1996","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2012.02.035_bb0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-2002-32661","article-title":"Preclinical pharmacology of albumin-free B-domain deleted recombinant factor VIII","volume":"28","author":"Brinkhous","year":"2002","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.thromres.2012.02.035_bb0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0038-1647482","article-title":"Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: The effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency","volume":"65","author":"Brassard","year":"1991","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.thromres.2012.02.035_bb0315","first-page":"403","article-title":"Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotype","volume":"140","author":"Nichols","year":"1992","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.thromres.2012.02.035_bb0320","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0301-5629(01)00499-9","article-title":"Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility","volume":"28","author":"Nightingale","year":"2002","journal-title":"Ultrasound Med Biol"},{"issue":"12","key":"10.1016\/j.thromres.2012.02.035_bb0325","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.ultrasmedbio.2011.09.006","article-title":"ARFI ultrasound monitoring of hemorrhage and hemostasis in vivo in canine von Willebrand disease and hemophilia","volume":"37","author":"Scola","year":"2011","journal-title":"Ultrasound Med Biol"},{"issue":"16","key":"10.1016\/j.thromres.2012.02.035_bb0330","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood-2008-07-168377","article-title":"Successful treatment of canine hemophilia by continuous expression of canine FVIIa","volume":"113","author":"Margaritis","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.thromres.2012.02.035_bb0335","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood.V81.10.2644.2644","article-title":"The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A","volume":"81","author":"Nichols","year":"1993","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2012.02.035_bb0340","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/016173460903100302","article-title":"ARFI ultrasound for in vivo hemostasis assessment postcardiac catheterization, part II: pilot clinical results","volume":"31","author":"Behler","year":"2009","journal-title":"Ultrason Imaging"},{"issue":"1","key":"10.1016\/j.thromres.2012.02.035_bb0200","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.amjcard.2003.08.077","article-title":"Effectiveness and safety of manual hemostasis facilitated by the SyvekPatch with one hour of bedrest after coronary angiography using six-French catheters","volume":"93","author":"Palmer","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2012.02.035_bb0345","first-page":"305","article-title":"Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures","volume":"14","author":"Nader","year":"2002","journal-title":"J Invasive Cardiol"},{"issue":"1 Suppl","key":"10.1016\/j.thromres.2012.02.035_bb0350","first-page":"S38","article-title":"Evaluation of poly-N-acetyl glucosamine as a hemostatic agent in patients undergoing cardiac catheterization: a double-blind, randomized study","volume":"57","author":"Najjar","year":"2004","journal-title":"J Trauma"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812000837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812000837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:35:43Z","timestamp":1758735343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384812000837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":42,"alternative-id":["S0049384812000837"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2012.02.035","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of current methods for assessing hemostasis in vivo and introduction to a potential alternative approach","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2012.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}